YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells.

We demonstrated previously that 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1), an activator of soluble guanylate cyclase (sGC), induces cyclooxygenase-2 (COX-2) expression via cGMP- and p44/42 mitogen-activated protein kinase-dependent pathways in human pulmonary epithelial A549 cells. In this study, we explore the role of Ras, phosphoinositide-3-OH-kinase (PI3K), Akt, and transcription factor nuclear factor-kappaB (NF-kappaB) in YC-1-induced COX-2 expression in A549 cells. A Ras inhibitor (manumycin A), a PI3K inhibitor (wortmannin), an Akt inhibitor (1l-6-Hydroxymethyl-chiro-inositol2-[(R)-2-O-methyl-3-O-octadecylcarbonate]), and an NF-kappaB inhibitor [pyrrolidine dithiocarbamate (PDTC)] all reduced YC-1-induced COX-2 expression. The YC-1-induced increase in COX activity was also blocked by manumycin A, wortmannin, PDTC, and the dominant-negative mutants for Ras (RasN17), Akt (Akt DN), and IkappaBalpha (IkappaBalphaM). The YC-1-induced increase in Ras activity was inhibited by an sGC inhibitor [1H-(1,2,4)oxadiazolo[4,3-a]quinozalin-1-one (ODQ)], a protein kinase G (PKG) inhibitor [1-oxo-9.12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-I][1,6]benzodiazocine-10-carboxylic acid methyl ester (KT-5823)], and manumycin A. YC-1-induced Akt activation was also inhibited by ODQ, KT-5823, manumycin A, and wortmannin. YC-1 caused the formation of an NF-kappaB-specific DNA-protein complex and an increase in kappaB-luciferase activity. YC-1-induced kappaB-luciferase activity was inhibited by ODQ, KT-5823, manumycin A, wortmannin, an Akt inhibitor, PDTC, RasN17, Akt DN, and IkappaBalphaM. Likewise, YC-1-induced IKKalpha/beta activation was inhibited by ODQ, KT-5823, manumycin A, wortmannin, and an Akt inhibitor. Furthermore, YC-1-induced COX-2 promoter activity was inhibited by manumycin A, RasN17, Akt DN, PDTC, and IkappaBalphaM. Taken together, these results indicate that YC-1 might activate the sGC/cGMP/PKG pathway to induce Ras and PI3K/Akt activation, which in turn initiates IKKalpha/beta and NF-kappaB activation and finally induces COX-2 expression in A549 cells.

[1]  T. Billiar,et al.  Nitric oxide prevents 6‐hydroxydopamine‐induced apoptosis in PC12 cells through cGMP‐dependent PI3 kinase/Akt activation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Horng-mo Lee,et al.  YC‐1 increases cyclo‐oxygenase‐2 expression through protein kinase G‐ and p44/42 mitogen‐activated protein kinase‐dependent pathways in A549 cells , 2002, British journal of pharmacology.

[3]  J. West,et al.  YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. , 2002, Biochemical and biophysical research communications.

[4]  E. Nånberg,et al.  Role of phosphoinositide 3OH‐kinase in autocrine transformation by PDGF‐BB * , 2001, Journal of cellular physiology.

[5]  H. Sheng,et al.  K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. , 2001, Cancer research.

[6]  S. Reddy,et al.  Transcriptional Regulation of the Cyclooxygenase-2 Gene in Activated Mast Cells* , 2000, The Journal of Biological Chemistry.

[7]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[8]  Chin‐Chung Wu,et al.  YC‐1 potentiates nitric oxide‐induced relaxation in guinea‐pig trachea , 1999, British journal of pharmacology.

[9]  P. Tsichlis,et al.  Differential Roles of Akt, Rac, and Ral in R-Ras-Mediated Cellular Transformation, Adhesion, and Survival , 1999, Molecular and Cellular Biology.

[10]  G. Schultz,et al.  YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. , 1998, Molecular pharmacology.

[11]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[12]  Jian-Dong Li,et al.  Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Der,et al.  Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.

[14]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[15]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[16]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[17]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[18]  K. Subbaramaiah,et al.  Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. , 1996, Cancer research.

[19]  J. Mitchell,et al.  Cyclooxygenase-2: regulation and relevance in inflammation. , 1995, Biochemical pharmacology.

[20]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[21]  S. Kuo,et al.  YC-1, a novel activator of platelet guanylate cyclase. , 1994, Blood.

[22]  F. McCormick,et al.  Activators and effectors of ras p21 proteins. , 1994, Current opinion in genetics & development.

[23]  F. Tamanoi,et al.  Identification of Ras farnesyltransferase inhibitors by microbial screening. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Nakafuku,et al.  Function of Ras as a molecular switch in signal transduction. , 1992, The Journal of biological chemistry.

[25]  D. Dewitt.  Prostaglandin endoperoxide synthase: regulation of enzyme expression. , 1991, Biochimica et biophysica acta.

[26]  L. Marnett,et al.  Prostaglandin endoperoxide synthase: structure and catalysis. , 1991, Biochimica et biophysica acta.

[27]  F. Chen,et al.  New insights into the role of nuclear factor-kappaB in cell growth regulation. , 2001, The American journal of pathology.

[28]  P. Tak,et al.  NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.

[29]  K. Ley,et al.  phosphatidylinositol-3-OH kinase , 2000 .

[30]  Y. Ho,et al.  Involvement of Protein Kinase C-γ in IL-1β-Induced Cyclooxygenase-2 Expression in Human Pulmonary Epithelial Cells , 2000 .

[31]  C. Garlanda,et al.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. , 2000, Science.

[32]  J. Romashkova,et al.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.

[33]  A. Weiss,et al.  Induction of NF-kappaB by the Akt/PKB kinase. , 1999, Current biology : CB.

[34]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[35]  L. Cantley,et al.  Phosphoinositide kinases. , 1998, Annual review of biochemistry.

[36]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.